Clinical Trial

Long-term Follow-up (LTFU) of Participants Who Received Azer-Cel

Name: Long-term Follow-up (LTFU) of Participants Who Received Azer-Cel — clinical trial record (NCT07577583)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The main objective of this study is to collect data on the long-term safety of azer-cel, primarily through the capture of clinical events of interest (CEI) for up to 15 years following participation in TG-Azercel -101 study.

Trial Details

NCT Number	NCT07577583
Lead Sponsor	TG Therapeutics, Inc.
Conditions	B-cell Mediated Autoimmune Disorders
Enrollment	32 participants
Start Date	2027-05-01
Primary Completion	2039-12-01 (estimated)
Study Completion	2039-12-01 (estimated)
Updated on ClinicalTrials.gov	2026-05-11